Introduction
Antibacterial resistance is currently one of the major problems encountered by clinicians in their work. The increasing prevalence of resistance to most antimicrobial agents complicates their use and the control of infectious diseases. Invasive medical interventions and the prolonged survival of many patients with chronic debilitating disease amplify the problem. One factor that affects the susceptibility of bacteria to antimicrobial agents is growth rate. 1 Thus, most antibiotics, in particular -lactams, are active only against rapidly growing bacteria. 2 Another factor is the low oxygen tension that may exist within some infected foci, for example, abscesses:
3 the inhibition of aminoglycoside uptake under anaerobic conditions was first demonstrated by Hancock in 1962. 4 Although various antibiotic families (e.g. fluoroquinolones and carbapenems), have been investigated for their activity against slow-growing bacteria, 5 no antimicrobial agent is at present fully effective against dormant anaerobic facultative bacteria subjected to low oxygen tensions.
Antimicrobial peptides are produced by both prokaryotic and eukaryotic cells 6 and have been the subject of many studies in recent years because of their involvement in host defence mechanisms and their potential use in therapeutics. They are now believed to be an essential defence component of invertebrates and vertebrates, including humans, destined to control cell proliferation and invading pathogens. Although the precise mechanism of action of antimicrobial peptides is not fully understood, they are believed to permeate the target cell by destabilizing its plasma membrane via either a 'barrel stave' mechanism or a non-pore carpet-like mechanism. 6 These antimicrobial peptides include the dermaseptins, a family of structurally and functionally related peptides that were originally isolated from the skin of tree frogs. 7 They are linear polycationic peptides, composed of 28-34 amino acids which are structured in amphipathic -helices in apolar solvents. 8 The antimicrobial action of dermaseptins is thought to be mediated by interaction of the amphipathic -helix with membrane phospholipids, resulting in lethal cell permeation. 6 They kill various pathogenic microorganisms, including bacteria, yeasts, protozoa and filamentous fungi. 6 In the present study, we have synthesized and purified to homogeneity four peptides (s1 to s4) with sequences corresponding to natural dermaseptins. We have compared their in-vitro activity against growing and non-growing Escherichia coli under different aeration conditions. We synthesized, and purified to homogeneity, four peptides with sequences corresponding to natural dermaseptins. We compared their in-vitro antibacterial potencies against growing and non-growing Escherichia coli cells under different oxygen conditions. The dermaseptins displayed different antibacterial potencies (MICs = 1-4 M). Killing assays showed that slowly growing bacteria were more susceptible to the synthetic replicates of dermaseptins than rapidly growing cells. In addition, the peptides displayed high efficacy in strictly anaerobic incubation conditions. These results suggest that synthetic dermaseptins are of potential interest in the eradication of bacteria placed in a dormant state and/or subjected to low oxygen tensions. (4 ) . The crude peptide was extracted from the resin with 40% acetonitrile in water, and purified to chromatographic homogeneity (98-99% purity) by reversed-phase HPLC using a C 18 column (Vydac, Hesperia, CA, USA) with a 40 min linear gradient of 30-80% acetonitrile in water (both containing 0.1% TFA). The purified peptide was subjected to amino acid analysis and fast atom bombardment (FAB) mass spectrometry in order to confirm its composition. Purified peptides were kept as lyophilized powders at -80°C. Before testing, fresh solutions (1 mg/mL) were prepared in water, briefly mixed by vortex, sonicated and centrifuged, then diluted in the required medium.
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MIC determinations
The MIC of peptides were determined by a standard broth microdilution technique using MGM, a minimal salt medium which had the following composition ( 
Bacterial strain and inoculum preparation
The E. coli clinical isolate used in this study was provided by the Bacteriology Laboratory of the Charles Nicolle Hospital (Rouen, France). The organisms were collected from stock cultures on Mueller-Hinton agar plates (Difco Laboratories, Detroit, MI, USA) and then grown overnight at 37°C on Mueller-Hinton agar slants. Colonies were picked off and suspended in 1 mL of MGM. After centrifugation of the bacterial suspension (at 2000g for 15 min), the pellet was washed and resuspended in 1 mL of MGM. Inocula were obtained from the resulting dense cell suspension. Cell populations were estimated by optical density measurements at 546 nm referred to a calibration curve.
Susceptibility tests
Killing assays were performed on rapidly and slowly growing cultures in 50 mL Erlenmeyer flasks containing 15 mL of culture medium supplemented with known peptide concentrations. Cultures growing in MGM (i.e. rapidly growing cultures) were exposed to 3 or 10 mg/L peptide (initial cell content 10 6 cfu/mL). The antibacterial efficacy of the peptides against slowly growing cultures was evaluated in a phosphate buffer (pH 7) enriched with 80 mM glucose. Experiments were carried out under moderate aeration where oxygen supply was ensured by transfer through the air-liquid interface in the culture flasks (k L a 0.8 min -1 ). Strictly anaerobic incubations were performed under continuous bubbling of sterile nitrogen gas.
After 3, 6 and 24 h of incubation, appropriate dilutions of the culture medium were plated on Mueller-Hinton agar plates. Colonies were counted after incubation of the plates for 24 h at 37°C. All counts were performed in triplicate.
Data analysis
All experiments were performed in duplicate. Calculations were performed using scientific software (Sigmaplot; Jandel Scientific, Corte Madera, CA, USA). Statistical analysis of data was done using Student's t-test.
Results and discussion
The growth rate of E. coli can be controlled by reducing the nitrogen and oligoelement sources. The cell population remained constant over incubation for 24 h in the glucose-enriched phosphate buffer (Table) . In strictly anaerobic conditions, E. coli generation time (c.1.5 h) was twice that observed in limited aeration conditions (c.0.7 h).
The synthetic replicates of dermaseptins varied in their ability to kill E. coli: the MICs of peptides s1, s2, s3 and s4 were 5, 12, 2.5 and 12 mg/L (i.e. 1.5, 3.5, 0.8 and 4.3 M) respectively. These results are in accordance with those already described for E. coli IP7624 using microplate assays (rank order of killing: s1 s2 s3 s4). 8 More pronounced differences in the antimicrobial potencies of dermaseptins have been described for the bacterium Nocardia brasiliensis (s3 s4 s2 s1). 7 Differences have also been reported in the ability of these four replicates to interact with human red blood cells: s4 is the only dermaseptin with haemolytic activity. 7 The differences in the abilities of these four synthetic peptides to kill Antibacterial activity of dermaseptins E. coli may result from differences in their structure and in the amino acid composition of their polar and hydrophobic faces. 8 The antibacterial activity of the most efficient peptide (s3) was compared in three cell incubation conditions (Figure, panel a) . A peptide concentration slightly over the MIC was used, namely 3 mg/L. Although s3 was bactericidal in all the three incubation conditions tested, its killing power was dependent on the bacterial growth rate. It was most active against non-growing organisms, killing all cells after 6 h of treatment. No regrowth was observed after incubation for 24 h (Table) . The oxygenation conditions did not affect the efficacy of the peptide in the first period of treatment (P > 0.05). In strictly anaerobic and limited aeration conditions, the cell population decreased by about 4 log units in 6 h. Nevertheless, after 24 h, regrowth occurred only in limited aeration conditions (Table) . When a higher peptide concentration (10 mg/L) was used, cultures were completely eradicated after 24 h, whatever the culture conditions (Table) . These results demonstrate the high antimicrobial activity of s3. We have shown previously, for example, that aminoglycoside and -lactam antibiotics (tobramycin and latamoxef) were inefficient against the same E. coli strain in similar incubation conditions. 9 Growth rate similarly affected the activities of peptides s1, s2 and s4. At a concentration of 3 mg/L (i.e. 0.6 MIC for peptide s1 and 0.25 MIC for peptides s2 and s4), cells grew in MGM whatever the aeration conditions, whereas more killing (three to four orders of magnitude more) was observed after incubation for 24 h in the medium that did not permit growth (Table) . At 10 mg/L (0.8 MIC), s4 killed non-growing cells, had a bacteriostatic effect in strict anaerobiosis and no killing effect under limited aeration conditions (Figure, panel b) .
In conclusion, dermaseptins efficiently kill slowly- growing and non-growing bacteria. They are also highly efficacious in strictly anaerobic incubation conditions. Slow growth or dormancy is often responsible for bacteria escaping the effects of antibiotics. Various hypotheses have been advanced to explain the enhanced resistance of adherent bacteria to antibiotics, in particular a growthrate-related effect 10 and oxygen limitation. 9 In this situation, the use of compounds with high bactericidal activity against non-proliferating bacteria is of obvious interest.
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